MannKind Corp (Nasdaq: MNKD) Looming FDA approval, Possible Buyout and a Billionaire CEO:
"While it is impossible to know if MNKD will ultimately receive FDA approval for Afrezza remains to be seen, I think their changes are excellent; if they do then shareholders could be in for incredible gains as the Company grabs a share of this staggering $58 billion global diabetes markets."
http://chartpoppers.com/mannkind-corp-nasdaq-mnkd-looming-fda-approval-possible-buyout-and-a-billionaire-ceo/